Which is better, MDT or RMD?

On the Buffett-Fit framework, ResMed Inc. (RMD) currently grades higher than MDT — 64/100 (C grade) vs 50/100 (C). That said, "better" depends on which framework you trust — MDT wins on none; RMD wins on Warren Buffett, Benjamin Graham, Philip Fisher, Peter Lynch, Joel Greenblatt, Charlie Munger, and Terry Smith. The full pillar breakdown is on this page.

Should I buy MDT or RMD?

This page is an educational comparison, not investment advice. Both MDT and RMD are graded against the same Buffett 5-pillar framework (moat, earnings durability, management quality, financial health, valuation) plus six other documented investor frameworks. Read the side-by-side breakdown to see which one matches the criteria you care about most — and always do your own research before making any investment decision.

Is MDT better than RMD for value investing?

On the Buffett-style value-investing framework, RMD currently grades higher — 64/100 vs 50/100, a 14-point gap. The gap is driven by which pillars each stock passes; the table on this page shows moat, durability, management, financial health, and valuation side-by-side.

What's the difference between MDT and RMD on Warren Buffett's framework?

Both stocks are evaluated on the same five pillars: economic moat (durable competitive advantage), earnings durability (consistent profitability), management quality (capital allocation), financial health (conservative balance sheet), and valuation (margin of safety). MDT currently scores 50/100 (C grade); RMD scores 64/100 (C grade). The "Where each wins" section on this page breaks down which pillar each stock dominates.

Which has the stronger moat, MDT or RMD?

Moat strength is one of the five pillars in the Buffett-Fit score on this page. MDT and RMD are each scored on ROIC sustainability, gross-margin durability, and qualitative signals like brand strength, switching costs, network effects, and regulatory barriers. The pillar breakdown on this page shows the moat sub-score side-by-side so you can see which one has the more durable competitive advantage.

Which is more undervalued, MDT or RMD?

Valuation is one of the five Buffett-Fit pillars on this page. Both stocks are scored on owner-earnings yield, price-to-intrinsic-value vs the underlying compounding rate, and the margin of safety relative to a conservative DCF. The valuation sub-score in the table below tells you which one currently trades at a more attractive price relative to its underlying business quality.

Are MDT and RMD both Healthcare stocks?

Yes — both Medtronic plc (MDT) and ResMed Inc. (RMD) operate in the Healthcare sector. That makes this a direct sector-peer comparison, which is the apples-to-apples way to use the Buffett-Fit framework: the score weighs each stock against its sector's specific quality and valuation benchmarks (sector-relative bonus), so the cross-stock comparison isn't distorted by inter-sector base-rate differences.

Is this MDT vs RMD comparison investment advice?

No. This page is an educational pattern-match against documented public frameworks (Buffett, Graham, Fisher, Lynch, Greenblatt, Munger, Smith), not personalised investment advice. The scores reflect how closely each stock matches each framework's documented criteria — they are not buy/hold/sell recommendations. Always do your own research and consult a licensed financial adviser for personalised advice.

Stock comparison

Medtronic

ResMed

Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.

MDT

Medtronic

Market cap

$97.84B

Sector

Healthcare

RMD

ResMed

Market cap

$29.57B

Sector

Healthcare

Overall winner

ResMed RMD

Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.

Fit scores by strategy

Strategy	MDT	RMD	Winner
Warren Buffett	50C	64C	RMD
Benjamin Graham	57C	67B	RMD
Philip Fisher	44D	67B	RMD
Peter Lynch	49D	50C	RMD
Joel Greenblatt	33F	39D	RMD
Charlie Munger	45D	61C	RMD
Terry Smith	46D	65B	RMD

Side-by-side metrics

Metric	MDT	RMD
Market cap	$97.84B	$29.57B
P/E (TTM)	21.2x	19.6x
EV/EBIT	21.0x	17.1x
ROIC (TTM)	6.43%	19.63%
Gross margin	61.95%	61.69%
Net margin	13.0%	27.44%
Revenue CAGR 5y	2.73%	12.64%
EPS CAGR 5y	7.88%	30.73%
Debt / Equity	0.6x	0.1x
Dividend yield	3.73%	1.14%

Where each one wins

The metrics with the biggest gap between the two - sorted so the most decisive edges read first.

MDT leads on

Market cap$97.84Bvs $29.57B+70%
Dividend yield3.73%vs 1.14%+69%

RMD leads on

Revenue CAGR 5y12.64%vs 2.73%+78%
Debt / Equity0.1xvs 0.6x+77%
EPS CAGR 5y30.73%vs 7.88%+74%
ROIC (TTM)19.63%vs 6.43%+67%

Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.

Medtronic

ResMed

Fit scores by strategy

Side-by-side metrics

Where each one wins

More like MDT

More like RMD

Related on invest-like

Key terms in this analysis